InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Quart Barry D, Chief Executive Officer. Director active across 3 companies, notably Heron Therapeutics, INC.. Cumulatively, 13 reports have been logged. Activity tracked since 30 April 2021. The latest transaction was filed on 31 October 2022 (J). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations13 total
4,373 sharesClass A Common ShareSEC:0001415889-24-015994:0
5,000 sharesClass A Common ShareSEC:0001415889-23-010559:0
1,655 shares@ US$3.272549.7% of flowCommon StockSEC:0001209191-23-003563:0
21,959 shares@ US$1.59100.0% of flowClass A Common ShareSEC:0001415889-22-011878:0
3,646 sharesCommon StockSEC:0001209191-22-053835:0
1,504 shares@ US$3.84250.3% of flowCommon StockSEC:0001209191-22-042262:0
3,646 sharesCommon StockSEC:0001209191-22-024522:0
3,646 sharesCommon StockSEC:0001209191-22-003362
3,646 sharesCommon StockSEC:0001209191-22-003362:0
3,646 sharesCommon StockSEC:0001209191-21-060551
3,646 sharesCommon StockSEC:0001209191-21-060551:0
1,529 shares@ US$13.897550.0% of flowCommon StockSEC:0001209191-21-046790
1,529 shares@ US$13.89750.0072% mcap50.0% of flowCommon StockSEC:0001209191-21-046790:0
13 of 13 declarations
About Quart Barry D
Barry D. Quart serves as Chief Executive Officer at HERON THERAPEUTICS, INC. /DE/. In this role, he is responsible for the strategic and operational leadership of the company. His expertise in management and business development enables him to guide HERON towards sustainable growth and continuous innovation. He collaborates closely with the management team to achieve the company's objectives.
